Phoenix pharmaceuticals INC:1109673 [18-000603]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN311201800026P
- Awardee
-
Phoenix Pharmaceuticals, Inc. UEI P8XLC937AAK3
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,782
Award facts
- Contract value 100% obligated
- $3,782.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Aging awarded a purchase order to Phoenix Pharmaceuticals, Inc. for $3,782.00 on November 15, 2017. Phoenix Pharmaceuticals is a minority-owned, Asian-Pacific American-owned manufacturer. The order is firm fixed price with no set-aside. Performance occurs in Baltimore, Maryland. The purchase order is scheduled for ultimate completion on December 15, 2017.
Quick answers
Who was awarded contract HHSN311201800026P?
HHSN311201800026P was awarded to Phoenix Pharmaceuticals, Inc. by National Institute on Aging (National Institutes of Health) on November 15, 2017.
How much is contract HHSN311201800026P worth?
The government has obligated $3,782 on HHSN311201800026P.
Was contract HHSN311201800026P competed?
The extent of competition for HHSN311201800026P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award